Biogen | BIIB - Pe Prix À Revenus





Pe Changement Date
AbbVie 23.03 1 2026-03
Acadia Pharmaceuticals 10.08 1.53 2026-03
ALKERMES 39.33 19.8 2026-03
Amgen 19.84 5.47 2026-03
Bayer 3.4 8.75 2026-03
Biogen 13.7 0.32 2026-03
BioMarin Pharmaceutical 15.28 3.96 2026-03
Bristol-Myers Squibb 9.08 0.2 2026-03
Eli Lilly 40.27 0.06 2026-03
Esperion Therapeutics 129.79 129 2024-12
Gilead Sciences 17.7 2.07 2026-03
Incyte 15.35 0.51 2026-03
Merck 16.52 2.6 2026-03
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 28.09 807.38 2026-03
Novartis 20.17 2.32 2026-03
Pfizer 9.32 5.16 2026-03
PTC Therapeutics 9.98 3.25 2025-12
Puma Biotechnology 13.93 44.88 2024-06
Regeneron Pharmaceuticals 25.14 7.03 2026-03
Sanofi 11.84 0.14 2026-03
Sanofi 15.75 1.53 2025-12
Sarepta Therapeutics 27.27 0 2025-12
Teva Pharmaceutical Industries 10.07 0.04 2026-03
United Therapeutics 20.42 3.1 2026-03
Vertex Pharmaceuticals 25.82 0.33 2026-03